Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma. (Q39471805)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2013

Language	Label	Description	Also known as
English	Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.	scientific article published on June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Jiaxin Xie

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yuwei Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Qi Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yifang Han

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jianhua Yin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rui Pu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Qiuxia Shen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Wei Lu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jun Zhao

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Xue Han

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Hongwei Zhang

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Guangwen Cao

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

1 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2369-2377

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Mutations within enhancer II and BCP regions of hepatitis B virus in relation to advanced liver diseases in patients infected with subgenotype B3 in Indonesia.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

NF-κB and STAT3 - key players in liver inflammation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Targeting the interleukin-6/Jak/stat pathway in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

HBx protein of hepatitis B virus activates Jak1-STAT signaling

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Genetic polymorphisms in inflammation pathway genes and prostate cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Dietary Saturated Fat Modulates the Association between STAT3 Polymorphisms and Abdominal Obesity in Adults

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

21 January 2018

Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26303

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26303

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23386590%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39471805&oldid=2168312052"